 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 09/16/2019 |
$2.52 |
$2.56 |
$2.46 |
$2.50 |
42.50K | | 09/17/2019 |
$2.49 |
$2.56 |
$2.44 |
$2.48 |
54.50K | | 09/18/2019 |
$2.47 |
$2.51 |
$2.38 |
$2.39 |
65.60K | | 09/19/2019 |
$2.38 |
$2.47 |
$2.38 |
$2.38 |
31.90K | | 09/20/2019 |
$2.38 |
$2.50 |
$2.30 |
$2.39 |
161.20K |
|
|
| AgeX Therapeutics is a biotechnology company focused on the development and commercialization of novel therapeutics targeting human aging. Co.'s proprietary technology, based on telomerase-mediated cellular immortality and regenerative biology, allows Co. to utilize telomerase-expressing regenerative Pluripotent Stem Cells (“PSCs”) for the manufacture of cell-based therapies to regenerate tissues afflicted with age-related chronic degenerative disease. Co.'s products under development include two cell-based therapies derived from telomerase-positive PSCs and two product candidates derived from its proprietary induced Tissue Regeneration technology. | |
|
AgeX Therapeutics (AGE) has the following price history information. Looking back at AGE historical stock prices for the last five trading days, on September 16, 2019, AGE opened at $2.52, traded as high as $2.56 and as low as $2.46, and closed at $2.50. Trading volume was a total of 42.50K shares. On September 17, 2019, AGE opened at $2.49, traded as high as $2.56 and as low as $2.44, and closed at $2.48. Trading volume was a total of 54.50K shares. On September 18, 2019, AGE opened at $2.47, traded as high as $2.51 and as low as $2.38, and closed at $2.39. Trading volume was a total of 65.60K shares. On September 19, 2019, AGE opened at $2.38, traded as high as $2.47 and as low as $2.38, and closed at $2.38. Trading volume was a total of 31.90K shares. On September 20, 2019, AGE opened at $2.38, traded as high as $2.50 and as low as $2.30, and closed at $2.39. Trading volume was a total of 161.20K shares.
AGE Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into AgeX Therapeutics shares, starting with a $10,000 purchase of AGE, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
11/29/2018 |
|
| End date: |
09/20/2019 |
|
| Start price/share: |
$2.71 |
|
| End price/share: |
$2.39 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-11.81% |
|
| Annualized Gain: |
-14.66% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$8,819.00 |
|
| Years: |
0.81 |
|
|
|
| Date |
Close |
| 09/16/2019 | $2.50 | | 09/17/2019 | $2.48 | | 09/18/2019 | $2.39 | | 09/19/2019 | $2.38 | | 09/20/2019 | $2.39 |
|
|
